Wnt/β-Catenin Signaling in Development and Disease  by Clevers, Hans
Leading Edge
ReviewWnt/β-Catenin Signaling  
in Development and Disease
Hans Clevers1,*
1Hubrecht Laboratory and Utrecht University, Uppsalalaan 8, 3584CT, Utrecht, the Netherlands
*Contact: clevers@niob.knaw.nl
DOI 10.1016/j.cell.2006.10.018
A remarkable interdisciplinary effort has unraveled the WNT (Wingless and INT-1) signal 
transduction cascade over the last two decades. Wnt genes encode small secreted proteins 
that are found in all animal genomes. Wnt signaling is involved in virtually every aspect of 
embryonic development and also controls homeostatic self-renewal in a number of adult 
tissues. Germline mutations in the Wnt pathway cause several hereditary diseases, and 
somatic mutations are associated with cancer of the intestine and a variety of other tissues.The mouse wnt1 gene, originally named Int-1, was iden-
tified in 1982 by Nusse and Varmus as a preferential 
integration site for the Mouse Mammary Tumor Virus 
in virally induced breast tumors (Nusse and Varmus, 
1982). When sequenced, the Wnt1 proto-oncogene was 
seen to encode a secreted protein that is cysteine rich. 
Subsequently, Drosophila wingless (wg), which controls 
segment polarity during larval development (Nüsslein-
Volhard and Wieschaus, 1980), was shown to be a fly 
homolog of Wnt1 (Rijsewijk et al., 1987). Segmentation 
of the epidermis of wg mutant fly embryos is severely 
impaired as evidenced by abnormalities in the overlying 
ventral cuticle. In contrast to the wild-type cuticle, which 
exhibits alternating denticle and naked belts, the wg cuti-
cle is completely covered with denticles. Fly embryos 
carrying mutations in the porcupine, dishevelled, and 
armadillo genes display similar cuticle abnormalities 
to wg mutant embryos, whereas mutations in shaggy/
zeste-white 3 cause the opposite phenotype, a naked 
cuticle. Epistatic analysis of cuticle structure in double 
mutants indicated that these genes constituted the core 
of a new signal transduction cascade (Siegfried et al., 
1992; Noordermeer et al., 1994; Peifer et al., 1994).
In 1989, McMahon and Moon (McMahon and Moon, 
1989) observed a duplication of the body axis in Xeno-
pus following injection of mouse Wnt1 mRNA into ventral 
blastomeres of embryos at the 4-cell stage. This observa-
tion supported the notion that Wnt signaling was shared 
between vertebrates and invertebrates and, moreover, 
provided a rapid and convenient assay to study compo-
nents of the Wnt pathway in vertebrates. Axis duplication 
was also induced by Dishevelled (Dsh), β-catenin (the 
vertebrate homolog of armadillo), and a dominant-nega-
tive version of glycogen synthase kinase 3 (GSK3), the 
vertebrate homolog of shaggy/zeste-white 3 (Dominguez 
et al., 1995; Guger and Gumbiner, 1995; He et al., 1995). 
Although long elusive, the specific Wnt signal that trig-
gers axis induction in Xenopus was identified as Wnt11 by 
Heasman and colleagues last year (Tao et al., 2005).The combined observations made in Drosophila and 
Xenopus delineated a highly conserved signaling path-
way, activated by secreted Wnt proteins. Independent 
of these studies, the adenomatous polyposis coli (APC) 
gene was discovered in a hereditary cancer syndrome 
termed familial adenomatous polyposis (FAP) (Kinzler 
et al., 1991; Nishisho et al., 1991). Soon after, the large 
cytoplasmic APC protein was found to interact with 
β-catenin (Rubinfeld et al., 1993; Su et al., 1993). This 
observation provided the first connection between the 
Wnt pathway and human cancer.
Genome sequencing has since revealed that mammalian 
species have roughly 20 secreted Wnt proteins, which can 
be divided into 12 conserved Wnt subfamilies. Of these, 
only 6 subfamilies have counterparts in ecdysozoan ani-
mals such as Drosophila and Caenorhabditis. In contrast, 
at least 11 of the Wnt subfamilies occur in the genome of 
a cnidarian (the sea anemone Nematostella vectensis). 
This finding suggests that some Wnt subfamilies were lost 
during the evolution of the ecdysozoan lineage but more 
importantly reveals that a complex inventory of Wnt factors 
was present in multicellular animals well before the Cam-
brian explosion (550 million years ago). Thus, comparative 
genomic analysis underscores the crucial role that Wnt 
genes play in organismal patterning throughout the animal 
kingdom (Kusserow et al., 2005).
Currently, three different pathways are believed to be 
activated upon Wnt receptor activation: the canonical 
Wnt/β-catenin cascade, the noncanonical planar cell 
polarity (PCP) pathway, and the Wnt/Ca2+ pathway. Of 
these three, the canonical pathway is best understood 
and is the primary subject of this review. For recent com-
prehensive overviews on the other Wnt signaling path-
ways, the reader is referred to Katoh (2005) and Kohn and 
Moon (2005). This review discusses how Wnt proteins are 
produced and secreted and how they activate the canoni-
cal Wnt signaling pathway in recipient cells. Further, the 
review examines the roles of the canonical Wnt pathway 
in development, tissue self-renewal, and cancer.Cell 127, November 3, 2006 ©2006 Elsevier Inc. 469
Wnt Protein Secretion
Wnt proteins are characterized by a high number of con-
served cysteine residues. Although Wnt proteins carry 
an N-terminal signal peptide and are secreted, they are 
relatively insoluble. This insolubility has been attributed 
to a particular protein modification, cysteine palmitoyla-
tion, which is essential for Wnt function (Willert et al., 
2003). Hofmann (2000) reported that a Drosophila gene 
required in the Wnt-secreting cell, termed porcupine, 
displays homology to acyl-transferases, enzymes that 
acylate a variety of substrates in the endoplasmic reticu-
lum. Thus, porcupine and its worm homolog mom-1 are 
believed to encode the enzyme that is responsible for 
Wnt palmitoylation (Zhai et al., 2004).
Recently, Banziger et al. (2006) and Bartscherer et 
al. (2006) uncovered in Drosophila another conserved 
gene that is essential for Wnt secretion, named wntless 
(wls) and evenness interrupted (evi), respectively. The 
gene encodes a seven-pass transmembrane protein 
that is conserved from worms (mom-3) to man (hWLS). 
In the absence of Wls/evi, Wnts are retained inside the 
cell that produces them. The Wntless protein resides pri-
marily in the Golgi apparatus, where it colocalizes and 
physically interacts with Wnts. A genetic screen in C. 
elegans revealed that the retromer, a multiprotein com-
plex involved in intracellular trafficking and conserved 
Figure 1. Wnt Secretion
To be secreted, Wnt proteins in the endoplasmic reticulum (ER) need 
to be palmitoylated by the action of Porcupine. Wnt proteins also re-
quire Wntless (Wls/Evi) in order to be routed to the outside of the cell. 
Loading onto lipoprotein particles may occur in a dedicated endo/ex-
ocytic compartment. The retromer complex may shuttle Wls between 
the Golgi and the endo/exocytic compartment.470 Cell 127, November 3, 2006 ©2006 Elsevier Inc.from yeast to man, is also essential for Wnt secretion 
and for the generation of a Wnt gradient (Coudreuse et 
al., 2006). An attractive hypothesis is that the retromer 
complex is involved in recycling a Wnt cargo receptor 
(such as Wntless) between the default secretory path-
way and a compartment dedicated to Wnt secretion (see 
Figure 1).
Wnt is thought to act as a morphogen (that is, a long-
range signal whose activity is concentration depend-
ent) (reviewed in Logan and Nusse, 2004). However, it is 
unclear how these long-range gradients are generated. 
It is conceivable that the palmitoyl moiety constrains 
movement away from membranes or lipid particles. 
Thus, Wnts may be tethered to intercellular transport 
vesicles or lipoprotein particles (Panakova et al., 2005). 
Alternatively, Wnts may be transported by cytonemes, 
which are long, thin filopodial processes. Additionally, 
studies in Drosophila suggest a role for extracellular 
heparan sulfate proteoglycans (HSPG) in the transport 
or stabilization of Wnt proteins. For instance, flies car-
rying mutations in Dally, a GPI-anchored HSPG, or in 
genes encoding enzymes that modify HSPGs resemble 
wingless mutants (reviewed in Lin, 2004).
Receptors, Agonists, and Antagonists for Wnt
Wnts bind Frizzled (Fz) proteins, which are seven-pass 
transmembrane receptors with an extracellular N-ter-
minal cysteine-rich domain (CRD) (Bhanot et al., 1996). 
The Wnt-Fz interaction appears promiscuous, in that 
a single Wnt can bind multiple Frizzled proteins (e.g., 
Bhanot et al., 1996) and vice versa. In binding Wnt, Fzs 
cooperate with a single-pass transmembrane molecule 
of the LRP family known as Arrow in Drosophila (Wehrli 
et al., 2000) and LRP5 and -6 in vertebrates (Pinson et 
al., 2000; Tamai et al., 2000). The transport of Arrow/
LRP5/6 to the cell surface is dependent on a chaper-
one called Boca in Drosophila and Mesd in mice (Culi 
and Mann, 2003; Hsieh et al., 2003). And consistent with 
a role of the Boca/Mesd chaperone in the transport of 
Arrow/LRP5/6 transport, mutations in Boca and Mesd 
resemble loss of Arrow/LRP5/6. Although it has not 
been formally demonstrated that Wnt molecules form 
trimeric complexes with LRP5/6 and Frizzled, surface 
expression of both receptors is required to initiate the 
Wnt signal.
Derailed, a transmembrane tyrosine kinase receptor 
from the RYK subfamily, is an unusual Wnt receptor. Dro-
sophila Wnt5 controls axon guidance in the central nerv-
ous system. Embryos lacking Dwnt-5 resemble those 
lacking Derailed, that is, they generate aberrant neuronal 
projections across the midline (Yoshikawa et al., 2003). 
Derailed binds DWnt-5 through its extracellular WIF (Wnt 
inhibitory factor) domain. Signaling events downstream 
of this alternative Wnt receptor remain unclear. Some-
what unexpectedly, the Derailed kinase domain may be 
dispensable for signaling. Lu et al. (2004) propose that, 
unlike the Drosophila Ryk homolog Derailed, mammalian 
Ryk functions as a coreceptor along with Fz. Mammalian 
Ryk binds Dishevelled to activate the canonical Wnt/
β-catenin signaling pathway. Another tyrosine kinase 
receptor, Ror2, harbors a Wnt binding CRD motif. Wnt5a 
can engage Ror2 to inhibit the canonical Wnt signaling 
pathway, although paradoxically Wnt5a can also activate 
the canonical pathway by directly engaging Fz4 (Mikels 
and Nusse, 2006) and Fz5 (He et al., 1997).
At least two types of proteins that are unrelated to 
Wnt factors activate the Frizzled/LRP receptors. One of 
these factors is the cysteine-knot protein Norrin, which 
is mutated in Norrie disease, a developmental disorder 
characterized by vascular abnormalities in the eye and 
blindness. Norrin binds with high affinity to Frizzled-
4 and activates the canonical signaling pathway in an 
LRP5/6-dependent fashion (Xu et al., 2004). Other fac-
tors that activate the canonical Wnt signaling pathway 
are R-spondins, which are thrombospondin domain-
containing proteins. In Xenopus, R-spondin-2 is a Wnt 
agonist that synergizes with Wnts to activate β-catenin 
(Kazanskaya et al., 2004). Human R-spondin-1 has been 
found to strongly promote the proliferation of intestinal 
crypt cells, a process which involves the stabilization of 
β-catenin (Kim et al., 2005). Indeed, studies in cultured 
cells demonstrate that R-spondins can physically inter-
act with the extracellular domains of LRP6 and Fzd8 and 
activate Wnt reporter genes (Nam et al., 2006).
The secreted Dickkopf (Dkk) proteins inhibit Wnt 
signaling by direct binding to LRP5/6 (Glinka et al., 
1998). Through this interaction, Dkk1 crosslinks LRP6 
to another class of transmembrane molecules, the Kre-
mens (Mao et al., 2002), thus promoting the internaliza-
tion and inactivation of LRP6. An unrelated secreted Wnt 
inhibitor, Wise, also acts by binding to LRP (Itasaki et al., 
2003), as does the WISE family member SOST (Li et al., 
2005; Semenov et al., 2005).
Soluble Frizzled-Related Proteins (SFRPs) resemble 
the ligand-binding CRD domain of the Frizzled family 
of Wnt receptors (Hoang et al., 1996). WIF proteins are 
secreted molecules with similarity to the extracellular 
portion of the Derailed/RYK class of transmembrane 
Wnt receptors (Hsieh et al., 1999). SFRPs and WIFs 
are believed to function as extracellular Wnt inhibitors 
(reviewed in Logan and Nusse, 2004) but, depending on 
context, may also promote signaling by Wnt stabilization 
or by facilitating Wnt secretion or transport.
Canonical Wnt Signaling
Once bound by their cognate ligands, the Fz/LRP 
coreceptor complex activates the canonical signal-
ing pathway (Figure 2). Fz can physically interact with 
Dsh, a cytoplasmic protein that functions upstream of 
β-catenin and the kinase GSK-3. Wnt signaling controls 
phosphorylation of Dsh (reviewed in Wallingford and 
Habas, 2005). However, it remains unclear whether the 
binding of Wnt to Fz regulates a direct Fz-Dsh interac-
tion, nor is it known how Dsh phosphorylation is con-
trolled or how phosphorylated Dsh functions in Wnt 
signal transduction.Recent studies have indicated that the coreceptor 
LRP5/6 interacts with Axin through five phosphorylated 
PPP(S/T)P repeats in the cytoplasmic tail of LRP (David-
son et al., 2005; Zeng et al., 2005). Wnts are thought 
to induce the phosphorylation of the cytoplasmic tail of 
LRP, thus regulating the docking of Axin. GSK3 phos-
phorylates the PPP(S/T)P motif, whereas caseine kinase 
I-γ (CK1γ) phosphorylates multiple motifs close to the 
GSK3 sites. CK1γ is unique within the CK1 family in that it 
is anchored in the membrane through C-terminal palmi-
toylation. Both kinases are essential for signal initia-
tion. It remains presently debated whether Wnt controls 
GSK3-mediated phosphorylation of LRP5/6 (Zeng et al., 
2005) or whether CK1γ is the kinase regulated by Wnt 
(Davidson et al., 2005). When bound to their respective 
membrane receptors, Dsh and Axin may cooperatively 
mediate downstream activation events by heterodimeri-
zation through their respective DIX (Dishevelled-Axin) 
domains.
The Cytoplasmic Destruction Complex
The central player in the canonical Wnt cascade is β-
catenin, a cytoplasmic protein whose stability is regu-
lated by the destruction complex. The tumor suppressor 
protein Axin acts as the scaffold of this complex as it 
directly interacts with all other components—β-catenin, 
the tumor suppressor protein APC, and the two kinase 
Figure 2. Canonical Wnt Signaling
(Left panel) When Wnt receptor complexes are not bound by ligand, 
the serine/threonine kinases, CK1 and GSK3α/β, phosphorylate β-
catenin. Phosphorylated β-catenin is recognized by the F box/WD 
repeat protein β-TrCP, a component of a dedicated E3 ubiquitin ligase 
complex. Following ubiquitination, β-catenin is targeted for rapid de-
struction by the proteasome. In the nucleus, the binding of Groucho to 
TCF (T cell factor) inhibits the transcription of Wnt target genes. (Right 
panel) Once bound by Wnt, the Frizzled(Fz)/LRP coreceptor complex 
activates the canonical signaling pathway. Fz interacts with Dsh, a cy-
toplasmic protein that functions upstream of β-catenin and the kinase 
GSK3β. Wnt signaling controls phosphorylation of Dishevelled (Dsh). 
Wnts are thought to induce the phosphorylation of LRP by GSK3β 
and casein kinase I-γ (CK1γ), thus regulating the docking of Axin. The 
recruitment of Axin away from the destruction complex leads to the 
stabilization of β-catenin. In the nucleus, β-catenin displaces Groucho 
from Tcf/Lef to promote the transcription of Wnt target genes.Cell 127, November 3, 2006 ©2006 Elsevier Inc. 471
families (CK1α, -δ, -ε and GSK3α and -β [reviewed in 
Price, 2006]). When WNT receptor complexes are not 
engaged, CK1 and GSK3α/β sequentially phosphor-
ylate β-catenin at a series of highly conserved Ser/Thr 
residues near its N terminus (Figure 2). Phosphorylated 
β-catenin is then recognized by the F box/WD repeat 
protein β-TrCP, a component of a dedicated E3 ubiq-
uitin ligase complex. As a consequence, β-catenin is 
ubiquitinated and targeted for rapid destruction by the 
proteasome (Aberle et al., 1997). Note that the CK1 and 
GSK3 kinases perform paradoxical roles in the Wnt 
pathway. At the level of the LRP coreceptor they act as 
agonists, whereas in the destruction complex they act 
as antagonists
Although genetic observations imply an essential role 
for APC in the destruction complex, there is no consen-
sus on its specific molecular activity. APC has a series of 
15 and 20 amino acid repeats with which it interacts with 
β-catenin. Three Axin-binding motifs are interspersed 
between these β-catenin-binding motifs. Increasing the 
expression of Axin in cancer cells that lack APC restores 
the activity of the destruction complex, implying that APC 
is only essential when Axin levels are limiting. Quantita-
tively, Axin indeed appears to be the limiting factor (Lee 
et al., 2003) and may be the key scaffolding molecule 
that promotes the rapid assembly and disassembly of 
the destruction complex.
Given that CK1, Dsh, β-TrCP, and GSK3 participate in 
other signaling pathways, low levels of Axin may insu-
late the Wnt pathway from changes in the abundance 
or activity of these signaling components. It has been 
proposed that APC is required for efficient shuttling and 
loading/unloading of β-catenin onto the cytoplasmic 
destruction complex. Both APC and Axin can them-
selves be phosphorylated by their associated kinases, 
Figure 3. Transactivation of Wnt Target Genes
The β-catenin/Tcf complex interacts with a variety of chromatin-remod-
eling complexes to activate transcription of Wnt target genes. The re-
cruitment of β-catenin to Tcf target genes affects local chromatin in sev-
eral ways. Bcl9 acts as a bridge between Pygopus and the N terminus 
of β-catenin. Evidence suggests that this trimeric complex is involved 
in nuclear import/retention of β-catenin (Townsley et al., 2004), but it 
may also be involved in the ability of β-catenin to activate transcrip-
tion (Hoffmans et al., 2005). The C terminus of β-catenin also binds to 
coactivators such as the histone acetylase CBP, Hyrax, and Brg-1 (a 
component of the SWI/SNF chromatin-remodeling complex).472 Cell 127, November 3, 2006 ©2006 Elsevier Inc.which changes their affinity for other components of 
the destruction complex. Our understanding of the rel-
evance of these phosphorylation events in the regulation 
of Wnt signaling remains incomplete. For a comprehen-
sive discussion of the kinases in the Wnt pathway, the 
reader is referred to a recent review (Price, 2006)
β-catenin plays a second role in simple epithelia, that 
is, as a component of adherens junctions. It is an essen-
tial binding partner for the cytoplasmic tail of various 
cadherins, such as E-cadherin (Peifer et al., 1992). Unlike 
the signaling pool of β-catenin, the pool that is bound 
to the adherens junction is highly stable. It is currently 
unclear whether the adhesive and signaling properties 
of β-catenin are interconnected. In a likely scenario, 
newly synthesized β-catenin first saturates the pool that 
is part of the adhesion junction, which never becomes 
available for signaling. “Excess,” free cytoplasmic β-
catenin protein is then efficiently degraded by the APC 
complex. It is only this second, highly unstable pool that 
is subject to regulation by Wnt signals. In support of this 
model, these two functions of β-catenin are separately 
performed by two different β-catenin homologs in C. 
elegans (Korswagen et al., 2000).
Upon receptor activation by WNT ligands, the intrinsic 
kinase activity of the APC complex for β-catenin is inhib-
ited. It is unclear how this occurs, but it likely involves the 
Wnt-induced recruitment of Axin to the phosphorylated 
tail of LRP and/or to Fz-bound Dsh. As a consequence, 
stable, nonphosphorylated β-catenin accumulates and 
translocates into the nucleus, where it binds to the N 
terminus of LEF/TCF (lymphoid enhancer factor/T cell 
factor) transcription factors (Behrens et al., 1996; Mole-
naar et al., 1996; van de Wetering et al., 1997).
It has been suggested that protein phosphatases 
may regulate β-catenin stability as antagonists of the 
serine kinases (reviewed in Price, 2006). For example, 
heterotrimeric PP2A is required for the elevation of 
β-catenin levels that is dependent on Wnt. Moroever, 
PP2A can bind Axin and APC, suggesting that it might 
function to dephosphorylate GSK3 substrates. If and 
how PP2A activity is regulated by Wnt signals remains 
to be resolved.
Crystallographic studies are starting to provide 
insights into the structure of the destruction complex. 
The central region of β-catenin (to which most partners 
bind) was the first component of the pathway to be crys-
tallized. It consists of 12 armadillo repeats, which adopt 
a superhelical shape with a basic groove running along 
its length. Subsequently, structural interactions of Axin, 
APC, E-cadherin, and TCF with β-catenin have been vis-
ualized (Choi et al., 2006, and references therein). APC, 
E-cadherin, and TCF bind the central part of the basic 
groove in a mutually exclusive fashion. Despite very lim-
ited conservation of primary sequence in the respective 
interaction domains, the modes of binding are structur-
ally very similar. Axin utilizes a helix that occupies the 
groove formed by the third and fourth armadillo repeats 
of β-catenin. Axin binding precludes the simultaneous 
interaction with other β-catenin partners in this region. 
Based on this observation, it is suggested that a key 
function of APC is to remove phosphorylated β-catenin 
from the active site of the complex (Xing et al., 2003). 
In a further study, the structure of Axin bound to APC 
(Spink et al., 2000) was solved. These studies form step-
ping stones to a better understanding of the dynamics 
of the destruction complex. Unfortunately, biochemical 
studies of the destruction complex in its different activa-
tion states are sorely lacking.
Nuclear Events
Upon stabilization by Wnt signals, β-catenin enters the 
nucleus to reprogram the responding cell (Figure 3). 
There is no consensus on the mechanism by which β-
catenin travels between the cytoplasm and the nucleus. 
In many cases, cells that undergo Wnt signaling may 
actually display an overall rise in β-catenin protein 
without a clear nuclear preference. β-catenin’s nuclear 
import is independent of the Nuclear Localization Sig-
nal/importin machinery. β-catenin itself is a close rela-
tive of importin/karyopherins and directly interacts with 
nuclear pore components. Two proteins, Tcf and Pygo-
pus are proposed to anchor β-catenin in the nucleus, 
although β-catenin can still localize to the nucleus in the 
absence of either of the two (reviewed in Staedeli et al., 
2006). β-catenin can also be actively transported back 
to the cytoplasm, by either an intrinsic export signal 
or as cargo of Axin (Cong and Varmus, 2004) or APC 
(Rosin-Arbesfeld et al., 2000) that shuttle between cyto-
plasm and nucleus.
Whereas the fly and worm genomes both encode a 
single Tcf protein, the vertebrate genome harbors four 
Tcf/Lef genes. Tcf factors bind their cognate motif in 
an unusual fashion, i.e., in the minor groove of the DNA 
helix, while inducing a dramatic bend of over 90°. Tcf 
target sites are highly conserved between the four ver-
tebrate Tcf/Lef proteins and Drosophila Tcf. These sites 
resemble AGATCAAAGG (van de Wetering et al., 1997). 
Wnt/TCF reporter plasmids such as pTOPflash (Korinek 
et al., 1997), widely used to measure Wnt pathway acti-
vation, consist of concatamers of 3–10 of these binding 
motifs cloned upstream of a minimal promoter. The four 
vertebrate TCF/LEF differ dramatically in their embry-
onic and adult expression domains, yet they are highly 
similar biochemically, explaining the extensive redun-
dancy unveiled in double knockout experiments (as in 
Galceran et al., 1999).
In the absence of Wnt signals, Tcf acts as a tran-
scriptional repressor by forming a complex with Grou-
cho/Grg/TLE proteins (Cavallo et al., 1998; Roose et al., 
1998). The interaction of β-catenin with the N terminus 
of Tcf (Behrens et al., 1996; Molenaar et al., 1996; van 
de Wetering et al., 1997) transiently converts it into an 
activator, translating the Wnt signal into the transient 
transcription of Tcf target genes. To accomplish this, 
β-catenin physically displaces Groucho from Tcf/Lef 
(Daniels and Weis, 2005). The recruitment of β-catenin 
to Tcf target genes affects local chromatin in several ways. Its C terminus is a potent transcriptional activa-
tor in transient reporter gene assays (van de Wetering 
et al., 1997). It binds coactivators such as the histone 
acetylase CBP and Brg-1, a component of the SWI/SNF 
chromatin remodeling complex (reviewed in Staedeli et 
al., 2006). A recent study implies that the human and 
fly homologs of yeast Cdc37 (Parafibromin and Hyrax, 
respectively) also interact with the C-terminal transacti-
vation domain of β-catenin to activate target gene tran-
scription (Mosimann et al., 2006). Cdc37 is a component 
of the PAF complex. In yeast the PAF complex directly 
interacts with RNA polymerase II to regulate transcrip-
tion initiation and elongation.
Two dedicated, nuclear partners of the TCF/β-cat-
enin complex, Legless/Bcl9 and Pygopus, were recently 
found in genetic screens in Drosophila (Kramps et al., 
2002; Parker et al., 2002; Thompson et al., 2002). Muta-
tions in these genes result in phenotypes similar to 
wingless, and overexpression of both genes promotes 
TCF/β-catenin activity in mammalian cells (Thompson 
et al., 2002). Bcl9 bridges Pygopus to the N terminus 
of β-catenin. The formation of this trimeric complex has 
been implicated in nuclear import/retention of β-catenin 
(Townsley et al., 2004) but may also directly contribute 
to the ability of β-catenin to transactivate transcription 
(Hoffmans et al., 2005). Although most if not all Wnt sig-
naling events in Drosophila appear to be dependent on 
Bcl9 and Pygopus, it is currently unclear if this holds true 
in vertebrate development.
Tcf itself can be regulated by phosphorylation. The 
MAP kinase-related protein kinase NLK/Nemo (Ishitani 
et al., 1999) phosphorylates Tcf, thereby decreasing the 
DNA-binding affinity of the β-catenin/Tcf complex and 
inhibiting transcriptional regulation of Wnt target genes. 
In C. elegans, LIT-1/NLK-dependent phosphorylation 
results in PAR-5/14-3-3- and CRM-1-dependent nuclear 
export of POP-1/Tcf (Meneghini et al., 1999; Lo et al., 
2004). And lastly, a recent study utilizing chromatin 
immunoprecipitations suggests that APC, independent 
of its role in the cytoplasmic destruction complex, acts 
on chromatin to facilitate CtBP-mediated repression of 
Wnt target genes in normal, but not in colorectal cancer 
cells (Sierra et al., 2006).
Wnt Target Genes
Loss of components of the Wnt pathway can produce 
dramatic phenotypes that affect a wide variety of organs 
and tissues. A popular view equates Wnt signaling with 
maintenance or activation of stem cells (Reya and Cle-
vers, 2005). It should be realized, however, that Wnt 
signals ultimately activate transcriptional programs and 
that there is no intrinsic restriction in the type of bio-
logical event that may be controlled by these programs. 
Thus, Wnt signals may promote cell proliferation and 
tissue expansion but also control fate determination or 
terminal differentiation of postmitotic cells. Sometimes, 
these disparate events, proliferation and terminal differ-
entiation, can be activated by Wnt in different cell types Cell 127, November 3, 2006 ©2006 Elsevier Inc. 473
Figure 4. Self-Renewing Tissues in the Adult Mammal
(Left) In the intestinal epithelium, proliferating crypt precursors and differentiated villus cells form a contiguous sheet of cells that is in per-
petual upward motion. Stem cells, which produce the transit-amplifying progenitor cells, reside near the bottom of the crypt and escape 
this flow. Evidence suggests that Wnt signaling is required for the establishment of the progenitor compartment in the intestinal epithelium. 
Wnt proteins also promote the terminal differentiation of Paneth cells at the base of the crypt. A small adenoma carrying a mutation in APC 
grows inside the right-hand villus. As a consequence of the loss of APC, β-catenin protein accumulates to high levels in the adenoma. (In-
set) A section of a mouse small intestine displaying crypts, villi, and a growing adenoma. Staining for β-catenin (brown) reveals its pres-
ence in adhesion junctions as well as a modest accumulation at the bottom of the crypts due to local Wnt signaling. Photo by Daniel Pinto. 
(Right) Wnt signaling in hair follicles activates bulge stem cells, promotes entry into the hair lineage, and recruits the cells to the transit-amplify-
ing matrix compartment.within the same structure, such as the hair follicle or the 
intestinal crypt (Reya and Clevers, 2005).
Numerous Tcf target genes have been identified in 
diverse biological systems. These studies tend to focus 
on target genes involved in cancer, as exemplified by the 
wide interest in the Wnt target genes cMyc and Cyclin 
D1. For a comprehensive, updated overview of Tcf tar-
get genes, the reader is referred to the Wnt homepage 
(http://www.stanford.edu/~rnusse/wntwindow.html). 
The Wnt pathway has distinct transcriptional outputs, 
which are determined by the developmental identity 
of the responding cell, rather than by the nature of the 
signal. In other words, the majority of Wnt target genes 
appear to be cell type specific. It is not clear whether 
“universal” Wnt/Tcf target genes exist. The best cur-
rent candidates in vertebrates are Axin2/conductin (Jho 
et al., 2002) and SP5 (Weidinger et al., 2005). As noted 
(Logan and Nusse, 2004), Wnt signaling is autoregulated 
at many levels. The expression of a variety of positive 
and negative regulators of the pathway, such as Friz-
zleds, LRP and HSPG, Axin2, and TCF/Lef are all con-
trolled by the β-catenin/TCF complex.
Wnt Signaling in Self-Renewing Tissues in Adult 
Mammals
Wnt signaling not only features in many developmental 
processes; in some self-renewing tissues in mammals it 
remains essential throughout life. It is this aspect of Wnt 474 Cell 127, November 3, 2006 ©2006 Elsevier Inc.signaling that is intricately connected to the development 
of disease. The examples discussed below illustrate how 
the Wnt pathway is involved in adult tissue self-renewal. 
Mutations in the Wnt pathway tip the homoeostatic bal-
ance in these tissues to cause pathological conditions 
such as disturbances in skeletal bone mass or cancer.
Gut
The absorptive epithelium of the small intestine is ordered 
into numerous villi and crypts. It constitutes the most 
rapidly self-renewing tissue in adult mammals. In the 
mouse, the epithelium turns over entirely within 3–5 days. 
A massive rate of cell production by a “transit-amplify-
ing” crypt compartment is compensated by apoptosis 
at the tip of the villus. The proliferating crypt precursors 
and differentiated villus cells form a contiguous sheet 
of cells that is in perpetual upward motion. Stem cells 
reside near the bottom of the crypt and escape this flow. 
These slowly cycling cells produce the transit-amplify-
ing progenitor cells that are capable of differentiating 
toward all epithelial lineages. The stem cells self-renew 
throughout life and regenerate the epithelium after injury 
(Figure 4). Committed progenitors arrest their cell cycle 
and differentiate when they reach the crypt-villus junc-
tion (reviewed in Reya and Clevers, 2005).
Current evidence indicates that the Wnt cascade is the 
dominant force in controlling cell fate along the crypt-vil-
lus axis. In neonatal mice lacking Tcf4, the differentiated 
villus epithelium appears unaffected, but the crypt pro-
genitor compartment is entirely absent (Korinek et al., 
1998). This implies that physiological Wnt signaling is 
required for the establishment of this progenitor com-
partment. Inhibition of Wnt signaling by the transgenic 
expression of Dkk-1 in adult mice induces the complete 
loss of crypts, identifying Wnt as the dominant mitogen 
for crypt progenitor cells throughout life (reviewed in 
Reya and Clevers, 2005). Transgenic expression of the 
Wnt agonist R-spondin-1 results in a massive hyperpro-
liferation of intestinal crypts, confirming this notion (Kim 
et al., 2005). Wnt proteins are physiologically expressed 
by the crypt epithelial cells rather than by the surround-
ing mesenchyme (Gregorieff et al., 2005). These Wnt 
proteins not only stimulate the proliferation of crypt pro-
genitors but also promote the terminal differentiation of 
Paneth cells, residing at the bottoms of the crypts (van 
Es et al., 2005).
Hair Follicle
Multipotent epidermal stem cells reside in the bulge 
region of the hair follicle (Figure 4). Bulge stem cells 
can generate all hair lineages but also the sebocytes 
and even the stem cells of the interfollicular epidermis 
(Alonso and Fuchs, 2003). To form a hair, cells migrate 
downward from the bulge through the outer root sheath. 
At the base of the hair, the cells enter a transit-amplifying 
compartment termed the germinative matrix where they 
undergo terminal differentiation in the precortex com-
partment of the hair.
Wnt signaling is required for the establishment of the 
hair follicle. Mice with a mutation in Lef1 have few hair 
follicles (van Genderen et al., 1994). Conversely, trans-
genic overexpression of Lef1 leads to de novo hair follicle 
formation in the epidermis. Similarly, transgenic overex-
pression of a constitutively stable (“oncogenic”) form of 
β-catenin induces additional hair follicles (reviewed in 
Alonso and Fuchs, 2003).
Within the established hair follicle, the Wnt cascade 
remains crucial throughout life. Wnt signals play a key 
role in the activation of bulge stem cells to progress 
toward hair formation, and this signal is relayed by β-
catenin and Lef1 (Lowry et al., 2005). Conditional dele-
tion of the β-catenin gene or transgenic expression of 
dominant-negative Lef1 in established hair follicles dis-
rupts the process by which bulge stem cells provide hair 
lineage precursors (Huelsken et al., 2001). Instead, the 
mutant cells adopt an epidermal or sebocyte fate. In 
sum, Wnt signaling in hair follicles, relayed through Lef1, 
activates bulge stem cells, promotes entry into the hair 
lineage, and recruits the cells to the transit-amplifying 
matrix compartment.
Multiple hair keratin genes carry Tcf binding sites in 
their promoters (Zhou et al., 1995), implying the coun-
terintuitive notion that Wnt signaling in the matrix, trans-
duced through β-catenin and Lef1, not only controls 
precursor cell expansion but also drives terminal dif-
ferentiation of the hair lineage. This situation resembles 
the terminal differentiation of Paneth cells by Wnt in the 
crypt (see above).Hematopoietic System
Hematopoietic stem cells (HSCs) are the best studied 
stem cells in mammals. A number of studies have impli-
cated the Wnt signaling pathway as an important regu-
lator of hematopoietic stem and progenitor cells. HSCs 
themselves as well as the bone marrow microenviron-
ment can produce Wnt proteins. Indeed, Tcf reporters 
are active in HSCs in their native microenvironment. 
In vitro, soluble Wnt proteins promote the proliferation 
and inhibit the differentiation of murine hematopoietic 
progenitors. In addition, overexpressed β-catenin as 
well as stimulation with purified Wnt proteins sustain 
self-renewal of murine and human HSCs in vitro. Such 
treated HSCs are enhanced in their ability to reconsti-
tute the hematopoietic system of lethally irradiated mice 
(Reya et al., 2003). Wnt signaling is also implicated in 
fate determination within the T lymphoid lineage as mice 
lacking either Tcf1 alone or both Tcf1 and Lef1 display 
severe reductions in the earliest thymocyte progenitor 
compartment (Okamura et al., 1998).
In the light of these observations it was unexpected 
that conditional deletion of β-catenin in mice did not 
affect the hematopoietic/lymphoid system (Cobas et al., 
2004). However, it remains possible that the loss of β-
catenin is compensated for in the hematopoietic system 
by its homolog γ-catenin/plakoglobin.
Bone
In postnatal and adult life, osteoblasts produce bone 
matrix, whereas osteoclasts resorb the matrix. Bone den-
sity is determined by the relative activities of these two 
cell types. Gain-of-function mutations in the human LRP5 
gene occur in bone diseases, indicating that canonical Wnt 
signaling may regulate bone mass. This observation has 
motivated genetic studies in mouse models, which gen-
erally confirm the importance of this signaling pathway in 
bone homeostasis, primarily as a positive regulator of the 
osteoblast lineage. Similar to humans carrying the gain-of-
function LRP5G171V mutation, transgenic mice expressing 
this allele in osteoblasts display increased bone density 
and elevated numbers of active osteoblasts (reviewed in 
Hartmann, 2006). Consistent with this notion, mice lack-
ing Lrp5 exhibit a reduction in bone mass and a defect in 
osteoblast proliferation and maturation (Kato et al., 2002). 
In addition, the loss of the SOST gene product sclerostin 
leads to sclerosteosis, a human disease characterized by 
high bone mass. Two groups recently demonstrated that 
SOST/Sclerostin is a secreted Wnt inhibitor, which binds 
and blocks LRP5/6 (Li et al., 2005; Semenov et al., 2005).
Several other mouse models support the notion that 
activated Wnt signaling leads to a postnatal increase in 
bone mass, such as transgenic mice expressing Wnt10b 
in adipose tissue and bone marrow and mice lacking 
the Wnt antagonist Sfrp1 (reviewed in Hartmann, 2006). 
Mice lacking Axin2 exhibit craniosynostosis as the result 
of increased proliferation of osteoblast progenitors in 
the skull sutures (Yu et al., 2005). These genetic stud-
ies indicate that osteoblast maturation and activity is 
induced by the canonical Wnt pathway.Cell 127, November 3, 2006 ©2006 Elsevier Inc. 475
Wnt Signaling in Cancer
Colon Cancer
The APC gene was among the first tumor suppressors 
to be cloned. A germline APC mutation is the genetic 
cause of a hereditary cancer syndrome termed Familiar 
Adenomatous Polyposis (FAP) (Kinzler et al., 1991; Nish-
isho et al., 1991). FAP patients inherit one defective APC 
allele and as a consequence develop large numbers of 
colon adenomas, or polyps, in early adulthood. Polyps 
are benign, clonal outgrowths of epithelial cells in which 
the second APC allele is inactivated. Inevitably, some of 
these polyps progress into malignant adenocarcinoma. 
Loss of both APC alleles occurs in the large majority 
of sporadic colorectal cancers (Kinzler and Vogelstein, 
1996). Mutational inactivation of APC leads to the inap-
propriate stabilization of β-catenin (Rubinfeld et al., 
1996; Figure 4). Indeed, Tcf reporter constructs, nor-
mally transcribed only upon Wnt signaling, are inappro-
priately transcribed in APC mutant cancer cells through 
the action of constitutive complexes between β-catenin 
and the intestinal TCF family member Tcf4 (Korinek et al., 
1997). In rare cases of colorectal cancer where APC is 
not mutated, Axin2 is mutant (Liu et al., 2000), or activat-
ing (oncogenic) point mutations in β-catenin remove its 
N-terminal Ser/Thr destruction motif (Morin et al., 1997). 
Of note, patients with hereditary Axin2 mutations display 
a predisposition to colon cancer (Lammi et al., 2004).
In intestinal epithelial cells in which APC is mutated, 
the constitutive β-catenin/Tcf4 complex activates a 
genetic program in crypt stem/progenitor cells (van 
de Wetering et al., 2002). In the crypt, the Wnt signal-
ing gradient drives expression of this genetic program 
to maintain progenitor cell proliferation. The Wnt gra-
dient also controls expression of the EphB/EphrinB 
sorting receptors and ligands (Battle et al., 2002). The 
resulting EphB/EphrinB countergradients establish 
crypt-villus boundaries as well as position the Paneth 
cells at the bottom of the crypt. Several EphB genes 
are initially upregulated as Wnt/Tcf4 target genes in 
early adenomas, but their expression is lost upon can-
cer progression (Batlle et al., 2005) apparently as the 
result of a selection process. Activating Wnt pathway 
mutations are not restricted to cancer of the intestine. 
Loss-of-function mutations in Axin have also been 
found in hepatocellular carcinomas, whereas onco-
genic β-catenin mutations occur in a wide variety of 
solid tumors (reviewed in Reya and Clevers, 2005).
Several animal models exist for FAP. Dove and col-
leagues first described the multiple intestinal neoplasia 
(min) mouse, which carries a stop codon in APC (Apc-
min). Unlike FAP patients, Apcmin mice develop adenomas 
predominantly in the small intestine (Su et al., 1992). 
Several additional Apc knockout models have been 
generated in mice. Invariably, these mice develop neo-
plastic lesions but they may differ in tumor incidence 
and tissue type in which tumors first appear. In a recent 
elegant study, the Wnt cascade was mutationally acti-
vated in adult mice by conditional deletion of Apc (San-476 Cell 127, November 3, 2006 ©2006 Elsevier Inc.som et al., 2004). Within days, villi were entirely popu-
lated by crypt-like cells, demonstrating the direct link 
between active Wnt signaling and the proliferation of 
crypt progenitors, which when unrestrained results in 
cancer. Zebrafish that are mutant in Apc resemble the 
mouse models in that heterozygous mutants develop 
adenomas in organs of endodermal origin including 
the intestine. These fish may prove useful for genetic 
screens for genes that modify cancer risk (Haramis et 
al., 2006).
Hair Follicle Tumors
The transit-amplifying matrix compartment of the hair 
follicle appears to be the target for malignant transfor-
mation by mutational activation of the Wnt cascade. A 
constitutively active, oncogenic β-catenin transgene 
induces pilomatricoma-like lesions (Gat et al., 1998), 
tumors whose exterior zone of densely packed cells 
resembles the hair follicle matrix. A tamoxifen-inducible 
β-catenin transgene induces another hair follicle tumor, 
a so-called trichofolliculoma (Lo Celso et al., 2004). 
Moreover, most spontaneous pilomatricomas in humans 
carry activating mutations in β-catenin (Chan et al., 
1999). Like adenomas in the gut, these pilomatricomas 
and trichofolliculomas subvert the process by which Wnt 
drives the physiological expansion of hair precursors in 
the matrix/precortex region of the hair.
Watt and colleagous recently described the first inac-
tivating mutations in the Wnt pathway in human cancer. 
One-third of a series of human sebaceous tumors car-
ried LEF1 mutations, impairing LEF1 binding to β-cat-
enin and transcriptional activation. This observation 
agrees with the model that entry of early progenitors 
into a hair fate requires Wnt signals transduced through 
Lef1. In the absence of such signaling, progenitors 
may be erroneously redirected toward a sebocyte fate 
(Takeda et al., 2006).
Leukemia
Drawing from the parallels between self-renewal and 
cancer in the gut and hair follicle, the effects of Wnt 
pathway components on hematopoietic progeni-
tors predict that Wnt deregulation may contribute to 
hematological malignancies. Indeed, a recent report 
suggests that leukemic growth of both myeloid and 
lymphoid lineages is dependent on Wnt signaling. 
Granulocyte-macrophage progenitors from Chronic 
Myelogenous Leukemia patients and blast crisis cells 
from patients resistant to therapy display active Wnt 
signaling as demonstrated by Tcf reporter activity and 
the accumulation of nuclear β-catenin (Jamieson et al., 
2004). The nature of the aberrant Wnt pathway activ-
ity is unresolved; no Wnt pathway mutations have been 
detected in hematological malignancies.
Future Challenges
Over the last 20 years, a detailed outline of the canonical 
Wnt pathway has emerged. Although it is likely that most 
core components of the pathway have now been identi-
fied, much remains to be learned about the biochemi-
cal events that connect these components. Many of 
the gaps in our knowledge are due to the notorious dif-
ficulties in the production of purified Wnt proteins. Few 
good Wnt antibodies exist and, 25 years after the clon-
ing of Wnt1, its structure remains unknown. The rout-
ing and the coincident posttranslational modifications 
of Wnt proteins in the secreting cell are incompletely 
understood. And the rules that dictate the movement of 
Wnt proteins between cells remain uncertain. However, 
a procedure to produce soluble Wnt has recently been 
developed (Willert et al., 2003), which creates avenues 
to address many of these issues.
The components of the destruction complex have 
been long known, yet the biochemistry of its activity has 
remained elusive. APC is an essential component of the 
destruction complex, but what is its biochemical activ-
ity? How relevant is Dsh for the coupling of Wnt recep-
tors to the destruction complex? And what mechanism 
inhibits the phosphorylation of β-catenin by the destruc-
tion complex when a Wnt signal is being transduced?
In addition, a multitude of proposed pathway com-
ponents, not discussed here, may activate, modify, or 
inhibit Wnt signaling or may be involved in crosstalk 
to other pathways. An updated, comprehensive list of 
these putative components and interactions appears 
on http://www.stanford.edu/~rnusse/wntwindow.html. 
Often based on single studies, these candidate compo-
nents remain to be independently confirmed.
Wnt signaling ultimately controls developmental fates 
through the transcription of cell type-specific programs 
of Tcf target genes. Recent developments in array-
based technology allow detailed analysis of the nuclear 
transcriptional response to Wnt signals. With these 
technologies, it is expected that the dissection of the 
gene programs in various developmental or pathologi-
cal events will provide a wealth of insight into the biol-
ogy of these processes. Such insights will be crucial 
for the development of targeted therapies for diseases 
related to the Wnt pathway. To date, the development of 
such therapies has unfortunately been lagging behind 
the rapid progress made in our fundamental under-
standing of this pathway. Small-molecule inhibitors of 
the Wnt pathway have proven difficult to develop but 
should hold great promise for the treatment of cancer. 
Agonists of the pathway have become available, such 
as small-molecule inhibitors of GSK-3 and soluble Wnt 
or R-spondin proteins. These may be used to support 
renewal or repair of tissues such as bone, hair, or dam-
aged intestinal epithelia.
The rapidly maturing Wnt field unites an unusually 
broad and effective spectrum of scientific disciplines. It 
can be expected that many of the outstanding questions 
in the field will be answered in the foreseeable future.
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